Detection limits of intraoperative near infrared imaging for tumor resection

Journal of Surgical Oncology

Volumn 102, Issue 7, 2010, Pages 758-764

  Thurber, Greg M ^a   Figueiredo, Jose Luiz ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antibody targeting; antigen expression; fluorescence; surgery

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON ADENOCARCINOMA; COLON CANCER; CONFOCAL LASER MICROSCOPY; EPIFLUORESCENCE MICROSCOPY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CARCINOMA; TUMOR MODEL; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; COLONIC NEOPLASMS; COMPUTER SIMULATION; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIMIT OF DETECTION; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MODELS, THEORETICAL; MONITORING, INTRAOPERATIVE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; TUMOR CELLS, CULTURED;

EID: 78649674920     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21735     Document Type: Article

References (39)

1. Weissleder R, Pittet MJ:, Imaging in the era of molecular oncology. Nature 2008; 452: 580-589.
2. Kirsch DG, Dinulescu DM, Miller JB, et al.: A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 2007; 13: 992-997.
3. Bristow RE, Tomacruz RS, Armstrong DK, et al.: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002; 20: 1248-1259.
4. Fatouros M, Roukos DH, Arampatzis I, et al.: Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther 2005; 5: 737-745.
5. Stummer W, Reulen HJ, Meinel T, et al.: Extent of resection and survival on glioblastoma multiforme-identification of and adjustment for bias. Neurosurgery 2008; 62: 564-574.
6. Nguyen QT, Olson ES, Aguilera TA, et al.: Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 2010; 107: 4317-4322.
7. Gerrand CH, Wunder JS, Kandel RA, et al.: Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg [Br] 2001; 83B: 1149-1155.
8. Lewis JJ, Leung D, Heslin M, et al.: Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol 1997; 15: 646-652.
9. Wasserberg N, Gutman H:, Resection margins in modern rectal cancer surgery. J Surg Oncol 2008; 98: 611-615.
10. Hoskins WJ, McGuire WP, Brady MF, et al.: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian-carcinoma. Am J Obstet Gynecol 1994; 170: 974-980.
11. Leblond F, Davis SC, Valdes PA, et al.: Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. J Photochem Photobiol B Biol 2010; 98: 77-94.
12. Graves EE, Weissleder R, Ntziachristos V:, Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 2004; 4: 419-430.
13. Ntziachristos V, Ripoll J, Weissleder R:, Would near-infrared fluorescence signals propagate through large human organs for clinical studies ? Opt Lett 2002; 27: 333-335.
14. Wang L, Wu H:, Biomedical optics. Hoboken, NJ Wiley; 2007.
15. Thurber GM, Zajic SC, Wittrup KD:, Theoretic criteria for antibody penetration into solid tumors and micrometastases. J Nucl Med 2007; 48: 995-999.
16. Thurber G, Figueiredo J, Weissleder R:, Multicolor fluorescent intravital live microscopy (FILM) for surgical tumor resection in a mouse xenograft model. PLoS ONE 2009; 4: e8053.
17. Nagi C, O'Grady TC, Izadpanah A:, Mohs micrographically controlled surgery and the treatment of malignant melanoma. Semin Oncol 2002; 29: 336-340.
18. Weissleder R, Ntziachristos V:, Shedding light onto live molecular targets. Nat Med 2003; 9: 123-128.
19. Kepshire D, Davis SC, Dehghani H, et al.: Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. Opt Express 2008; 16: 8581-8593.
20. Cheong WF, Prahl SA, Welch AJ:, A review of the optical properties of biological tissues. IEEE J Quantum Electr 1990; 26: 2166-2185.
21. Winter MJ, Nagtegaal ID, van Krieken J, et al.: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 2003; 163: 2139-2148.
22. Pande AU, Iyer RV, Rani A, et al.: Epidermal growth factor receptor-directed therapy in esophageal cancer. Oncology 2007; 73: 281-289.
23. Herbst RS, Shin DM:, Monoclonal antibodies to target epidermal growth factor receptor-positive tumorsa - A new paradigm for cancer therapy. Cancer 2002; 94: 1593-1611.
24. Wen YH, Koeppen H, Garcia R, et al.: Epidermal growth factor receptor in osteosarcoma: Expression and mutational analysis. Hum Pathol 2007; 38: 1184-1191.
25. Yang JL, Hannan MT, Russell PJ, et al.: Expression of HER1/EGFR protein in human soft tissue sarcomas. Eur J Surg Oncol 2006; 32: 466-468.
26. Andersson U, Guo D, Malmer B, et al.: Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 2004; 108: 135-142.
27. Heimberger AB, Suki D, Yang D, et al.: The natural history of EGFR and EGFRvIII in glioblastoma patients. J Translat Med 2005; 3: 6.
28. Wind J, Smit EJ, Senan S, et al.: Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg 2007; 32: 29-34.
29. Renehan AG, Egger M, Saunders MP, et al.: Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials. Br Med J 2002; 324: 813-816.
30. Themelis G, Yoo JS, Soh KS, et al.: Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt 2009; 14: 9.
31. Sheth RA, Upadhyay R, Stangenberg L, et al.: Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. Gynecol Oncol 2009; 112: 616-622.
32. De Grand AM, Frangioni JV:, An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2003; 2: 553-562.
33. Ishizawa T, Fukushima N, Shibahara J, et al.: Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009; 115: 2491-2504.
34. Kaushal S, McElroy MK, Luiken GA, et al.: Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 2008; 12: 1938-1950.
35. Zou P, Xu SB, Povoski SP, et al.: Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm 2009; 6: 428-440.
36. Longmire MR, Gunn AJ, Morgan NY, et al.: Real-time fluorescence-enhanced imaging as an aid to surgery in ovarian cancer. IEEE J Selected Top Quantum Electr 2007; 13: 1602-1609.
37. Veiseh M, Gabikian P, Bahrami SB, et al.: Tumor paint: A chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 2007; 67: 6882-6888.
38. Weissleder R, Tung CH, Mahmood U, et al.: In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999; 17: 375-378.
39. Bogaards A, Varma A, Collens SP, et al.: Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg Med 2004; 35: 181-190.